Physician profile
Mark William Burke
NPI 1811299324
$3,297.67
in general payments reported to CMS, 2019-2025
19 companies · $656 in 2025
The $656 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $37.39 · 2021: $441 · 2022: $530 · 2023: $506 · 2024: $227 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,361 · Entertainment: $29.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.05 |
| Entertainment | $29.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $778.60 | 2019-2025 | Precision 1, Total30, Precision7 |
| Bausch & Lomb Americas INC. | $461.38 | 2022-2025 | Infuse, Xiidra, Biotrue |
| Coopervision INC. | $423.95 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Glaukos Corporation | $316.54 | 2019-2025 | Idosetr, Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Sight Sciences, INC. | $292.93 | 2019-2022 | |
| Visioneering Technologies, INC. | $250.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $137.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $121.31 | 2019 | |
| Optos, INC. | $105.75 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $82.46 | 2025 | |
| Optovue, INC. | $55.92 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $49.45 | 2025 | Xdemvy |
| Rxsight INC | $46.65 | 2021 | |
| Lombart Brothers, INC. | $42.65 | 2025 | Opd-III |
| Ivantis, INC | $35.91 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Topcon Healthcare, INC. | $29.47 | 2025 | |
| Biotissue Holdings INC. | $28.36 | 2019 | |
| Iridex Corporation | $20.75 | 2021 | |
| Abb Con-Cise Optical Group LLC | $17.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.